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Abstract
Background: Bovine herpesvirus 5 (BoHV-5) is a member of the subfamily Alphaherpesvirinae responsible for
meningo-encephalitis in young cattle. The first case of bovine meningo-encephalitis associated with a herpesvirus
infection was reported in Australia. The current geographical distribution of BoHV-5 infection is mainly restricted to
South America, especially Brazil and Argentina. Outbreaks of BoHV-5 are regularly observed in Argentina suggesting
the circulation of the virus in the bovine population.
Results: Seventeen field strains of BoHV-5 isolated from 1984 to now were confirmed by differential PCR and
subjected to restriction endonuclease analysis (REA). Viral DNA was cleaved with BstEII which allows the
differentiation among subtypes a, b and non a, non b. According to the REA with BstEII, only one field strain
showed a pattern similar to the Argentinean A663 strain (prototype of BoHV-5b). All other isolates showed a clear
pattern similar to the Australian N569 strain (prototype of BoHV-5a) consistent with the subtypes observed in Brazil,
the other South-American country where BoHV-5 is known to be prevalent. The genomic region of subtype b
responsible for the distinct pattern was determined and amplified by PCR; specifically a point mutation was
identified in glycoprotein B gene, on the BstEII restriction site, which generates the profile specific of BoHV-5b.
Conclusions: This is the first report of circulation of BoHV-5a in Argentina as the prevailing subtype. Therefore the
circulation of BoHV-5b was restricted to a few years in Argentina, speculating that this subtype was not able to be
maintained in the bovine population. The mutation in the gB gene is associated with the difference in the
restriction patterns between subtypes “a” and “b”.
Background
Bovine herpesviruses 1 (BoHV-1) and 5 (BoHV-5) are
closely related alphaherpesviruses infecting cattle [1,2].
The major difference between BoHV-5 and BoHV-1 is
the distinct ability of the former to cause neurological
disease in cattle [3,4]. In a natural infection via the
respiratory tract, BoHV-1 and BoHV-5 replicate simi-
larly in the nasal mucosa but they differ in their neu-
roinvasiveness [5,6]. BoHV-1 neuroinvasion usually does
not go further than the first order neuron located in the
trigeminal ganglia, where the latent infection is estab-
lished, whereas BoHV-5 is able to infect different
regions of the brain [7-9].
The BoHV-5 genome is 137,821 base pairs (bp) long
and is approximately 2,000 bp longer than the BoHV-1
genome, with a G + C base composition of 75% [1,6].
These viruses exhibit an average of 82% amino acid iden-
tity amongst different proteins. The most similar proteins
(≥ 95% amino acid identity) are those involved in viral
DNA replication and processing of virion proteins [1,6].
Because of the great similarity between BoHV-1 and
BoHV-5, the differentiation by conventional techniques
such as viral isolation, immunofluorescence and neutra-
lization test is difficult and has implications for the diag-
nosis as well as for BoHV-1 vaccination and eradication
* Correspondence: aromera@cnia.inta.gov.ar
1Virology Institute, Veterinary and Agricultural Science Research Centre
(CICVyA), National Institute of Agricultural Technology (INTA), N. Repetto y
Los Reseros S/N, CC25 (B1712WAA), Castelar, Buenos Aires, Argentina
Full list of author information is available at the end of the article
Maidana et al. BMC Veterinary Research 2011, 7:8
http://www.biomedcentral.com/1746-6148/7/8
© 2011 Maidana et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
programs [10,11]. However, these viruses exhibit some
important genetic and immunogenic differences, which
would explain their pathogenic and epidemiological
characteristics [4,12,13]. BoHV-5 is the causal agent of
meningo-encephalitis; a condition of low morbidity and
high lethality. It usually affects cattle up to 8 months
old [14] although older animals can also be affected.
This neurological disease is associated with a variety of
clinical signs, including tremors, circling, bruxism,
incoordination and recumbency, followed by convul-
sions, padding and inevitable death [15,3,16,17,5].
Although sporadic cases of meningo-encephalitis by
BoHV-5 have been reported in Australia [3,18], Italy
[19] and Hungary [20], BoHV-5 infection and disease
are more frequent in Argentina and Brazil; where
numerous outbreaks have been described in the last
decades [16,21-24]. The rare occurrence of BoHV-5
neurological disease in areas where BoHV-1 infection is
endemic could be explained by cross-protection induced
by BoHV-1 natural infection or vaccination [25,2,26,27].
Restriction endonuclease analysis (REA) has been widely
used to compare BoHV-1 isolates [28,29]. It proved to be
particularly useful for the differentiation among various
ruminant alphaherpesviruses antigenically related to
BoHV-1, which show distinct DNA fingerprints [30,31].
Additionally, this technique allows the subtyping of viruses
that apparently belong to the same type [28,32].
Traditionally, the differentiation between BoHV-1 and
BoHV-5 is based on the clinico- epidemiological charac-
teristics of the outbreaks followed by REA of viral DNA
after virus isolation. However, it is not highly precise
because BoHV-1 can also be responsible for neurologi-
cal disease [33,34]. Furthermore, immunoassays using
monoclonal antibodies [4,35,36], PCR followed by REA
[37], nested PCR [13] and multiplex PCR [38-40] are
also available.
Different strains of BoHV-5 were previously classified
and designed as BoHV-5 “a"; BoHV-5 “b” and BoHV-5
“non-a, non-b” according to REA [4,41]. A subtle anti-
genic difference was shown between subtypes “a” and
“b” [4].
The first outbreak of BoHV-5 in Argentina was
described in 1982; when the reference strain A663 was
isolated. This viral strain was classified by REA as sub-
type “b” which has only been described in Argentina
so far. Therefore, the aims of this study are to compare
and characterize by REA the genomes of Argentinean
BoHV-5 isolates obtained from cattle with neurological
disease since 1984 until now. Furthermore, we identi-
fied the mutation that leads to the change in the
restriction pattern of the strain A663. We describe a
simple diagnostic method based on PCR-REA system
that allows an easy discrimination between BoHV-5 “a”
and “b” subtypes.
Results
Most of the isolates included in this study come from out-
breaks that occurred between 1982 and 2007 in Buenos
Aires province (Argentina). As summarized in Table 1,
most of the field BoHV-5 strains were isolated and
Table 1 Bovine herpesvirus 5 isolates and reference strains grouped in subtypes according to restriction endonuclease
analysis
Subtype Year Strain Sample Origin and Clinical Signs
a 1985 N569 Brain Australia - Encephalitis (Ref strain)
28 (30/5) Lung Argentina - No data
136/85 Brain Argentina -No data
75/85 Brain Argentina -No data
1989 67/89 9H Ocular Swabs Balcarce (Buenos Aires, Argentina). Ocular lesions, mouth and prepuce.
54/89 Lung Tandil (Buenos Aires, Argentina). Respiratory signs, 10% mortality.
1999 Balcarce Brain Balcarce (Buenos Aires, Argentina). Encephalitis
740 Brain Monte (Buenos Aires, Argentina). Encephalitis
730 Brain Benito Juarez (Buenos Aires, Argentina). Encephalitis.
742 Brain Coronel Suarez (Buenos Aires, Argentina). Encephalitis.
80458 Brain Daireux (Buenos Aires, Argentina). Congestion of the brain without malacia.
82159 Brain La Plata (Buenos Aires, Argentina). Necrosis in both frontal lobes of the brain.
81509 Brain No data. Brain with malacia in both frontal lobes.
2000 98413 Brain Guaminí (Buenos Aires, Argentina). Encephalitis.
2002 15520 Brain Santa Fe (Argentina). Encephalitis.
16697 Brain La Pampa (Argentina). Encephalitis.
2007 72082 Brain Monte (Buenos Aires, Argentina). No data.
b 1982 A663 Brain Argentina - Encephalitis (Ref. strain)
1984 S-N-59 (166/84) Brain Argentina - No data
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amplified from the brain of cattle affected with encephali-
tis. The virus was also isolated from ocular swabs and
from the lung of animals with respiratory disease. All
viruses isolated from tissues of cattle were successfully
amplified. PCR analysis allowed the differentiation
between BoHV-1 and BoHV-5 based on the size of the
PCR products (159 bp for BoHV-5 and 354 bp for BoHV-
1). All field isolates from cattle were BoHV-5 (figure 1).
Most field isolates (16 out of 17 isolates) showed a
BstEII REA pattern similar to the reference strain N569,
prototype of BoHV-5a (Figure 2). Only one field strain
(S-N-59 (166/84)) presented a REA pattern similar to
the Argentinean reference strain A663 prototype of
BoHV-5b. The S-N-59 (166/84) was isolated in 1984,
one year after the isolation of the strain A663 (Lane 4,
Figure 2).
A fragment of 534 pb of the UL27 gene, encoding the
BoHV-5 glycoprotein B (gB) from the reference strain of
BoHV-5 and seventeen isolates of BoHV-5 were
sequenced. A consistent alignment provided by a 500 bp
fragment from this gene revealed a point mutation (C to
T) in the BstEII restriction site of subtype “b” of BoHV-
5, responsible for the variation in the REA pattern. The
point mutation is shown in alignment with the reference
subtypes of BoHV-5 and the isolates (figure 3).
The specific 534-bp PCR product was consistently
obtained as a clear electrophoretic band from all isolates
and reference strains of BoHV-5. The digestion of the
PCR products with the restriction enzyme BstEII gener-
ated distinct restriction patterns depending on the origin
of the amplified viral DNA (BoHV-5 “a” or “b” sub-
types): 152 and 382 bp for BoHV-5 “a” subtype and 534
bp for BoHV-5 b (Figure 4)
Discussion
A high seroprevalence for BoHV-1 was reported in
Argentina [42]. By now, the proportion of this percentage
that can be attributed to BoHV-5 is unknown since diag-
nostic tests do not differentiate between anti- BoHV-1
and -BoHV-5 antibodies [10,26]. Although the clinical
manifestations of BoHV-1 and 5 are slightly different,
this is not sufficient to allow a precise distinction
between virus species. Furthermore, cases of meningo-
encephalitis can also be consequence of BoHV-1 infec-
tion [43]. Neighboring countries have reported the circu-
lation of BoHV-5 subtypes “a” and non-"a” non -"b”
although Argentina was the first and the only country to
report the isolation of a BoHV-5 strain belonging to sub-
type “b” [41,44].
It has been reported that some outbreaks attributed to
the subtype “a” group occurred with respiratory signs in
the absence of nervous manifestations (67/89 9H, 54/
89). Indeed, in diseased animals, virus infection is not
restricted to the central nervous system [21]. Further
studies will be required to determine why these BoHV-5
isolates were non-neuropathogenic under these natural
conditions.
Several outbreaks occurring between 1981 and 1984,
mainly in the central region of Argentina, were deter-
mined to be caused by BoHV-5 (9 out of 10 isolates)
[21]. In many cases there were no records of morbidity
and mortality, except for the outbreak in which the
strain A663 was isolated, where 15% (81 out of 540) ani-
mals died. Ten percent of the isolates recovered during
this period showed slower growth and smaller plaques
in tissue culture than the Jura strain of BoHV-1. In this
report, we also observed one isolate of BoHV-5 with
poor growth in cell culture (1/17), which was classified
as subtype “b”. This field strain was isolated in 1984
from a meningo-encephalitis outbreak in Arroyo Corto,
Saavedra district, located southwest of the Buenos Aires
province; the affected herd consisted of 158 bovines;
with only one fatality case. This farm had presented a
similar outbreak in July-August 1983. Interestingly, this
strain affected older animals (18 to 26 months) than the
historical case attributed to A663 (5 to 18 months).
According to our study, it is evident that in Argentina
both subtypes “a” and “b” circulated for some time and,
apparently the circulation of subtype “a” is more recent.
As in Brazil, the co-circulation of subtypes “a” and non
“a”, non “b” was reported [41], further studies are
required to determine whether subtype non “a” non “b”
is present or will appear in Argentina and whether sub-
type “b” will definitely disappeared.
In this study, we were also able to determine the region
of the subtype “b” genome which is responsible for the
different BstEII restriction patterns. The C-T substitution
observed in the gene encoding gB, a glycoprotein that is
involved in the entry and cell-to-cell spread of virus
[45-48] did not introduce an amino-acid change. The
digestion of the PCR products with the restriction
Figure 1 Ethidium bromide stained 1% agarose gel
electrophoresis of the amplified products by multiplex-PCR for
BoHV-1 (354 bp) and BoHV-5 (159 bp) glycoprotein C gene.
Marker used was 1 Kb plus marker (Invitrogen)
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Figure 2 BstEII restriction endonuclease profiles of the isolates and the reference strains. Marker: molecular weight marker (lambda Hind
III, Invitrogen).
Figure 3 Localization of the point mutation in the BoHV-5 subtype “b”. Multiple nucleotide alignment of 87 bp of the UL27 region
surrounding the mutation; the restriction site and the mutation are highlighted. Multiple amino-acid alignment of the gB region surrounding
the mutation; it is located in the third position (58295 nt position of the genome AY261359) of a threonine codon present in the three strains
analyzed, indicating that the mutation does not produce an amino acid change.
Maidana et al. BMC Veterinary Research 2011, 7:8
http://www.biomedcentral.com/1746-6148/7/8
Page 4 of 8
enzyme BstEII allowed the easy discrimination between
“a” and “b” subtypes The diagnostic system based on
PCR products has been tested on seventeen isolates and
references strains, however before considering the gen-
eral applicability of this assay it will be necessary to ana-
lyze more samples of all BoHV-5 subtypes.
The fragment amplified by PCR shows significant dif-
ferences at the amino-acid level when compared with
the published sequence of this portion of the gene. It
will be necessary to conduct further studies to prove
whether the changes present in the gB gene of subtype
“b” viruses can be related to a specific pattern of virus
spread and properties, as observed by Schudel and colla-
borators [21] regarding the formation of smaller plaques
in cell culture and slower growth kinetics with respect
to the reference virus.
A further epidemiological study would be required to
investigate why the circulation of subtype “b” viruses is
restricted to Argentina and why it was only observed in
1982 and 1984. It would also be important to determine
whether these isolates exhibit a distinct behavior in vivo.
Conclusion
According to our knowledge, this is the first report on
the circulation of BoHV-5 subtype “a” in Argentina. We
determined that a mutation in the gB gene is responsible
for the difference in the restriction pattern between sub-
types “a” and “b”. According to the number of samples
analyzed, most of the field isolates - including the current
ones - belong to subtype “a”. Subtype “b” was only iso-
lated during a transient period in 1982 and 1984, and
apparently is no longer circulating in the country.
Methods
Viruses and cells
BoHV-5 strains were obtained by isolation from samples
of naturally infected animals. The virus isolates used in
this study are shown in Table 1. They were collected
from our and other laboratories across Argentina. All
viruses were propagated in Madin Darby Bovine Kidney
(MDBK) cells grown in Eagle’s minimal essential med-
ium (E-MEM) supplemented with 2% fetal bovine serum
(FBS) [49]. The strains N569 and A663 representative of
BoHV-5 “a” and BoHV-5 “b” subtypes, respectively,
were used as reference viruses [4,41,50,51].
Viral DNA extraction
Viruses were inoculated in tissue culture flaks (175 cm2)
with nearly confluent, overnight grown MDBK mono-
layer, at a multiplicity of infection of 0.1 and incubated
at 37°C and 5% CO2. When cytopathic effect reached
80-90% (48 h), the culture medium was clarified by low
speed centrifugation and supernatant centrifuged at
100,000 × g for 1 h. The viral pellet was re-suspended in
buffer TE with 1% NP40 (10 mM Tris; 1mM EDTA; pH 8;
1% NP40) and incubated at 56°C in thermostatic bath.
The suspension was ultra-centrifuged in a saccharose gra-
dient at 100,000 × g. The viral pellet was re-suspended in
TE (10 mM Tris, 1 mM EDTA; pH 8) and treated with
10% sodium dodecyl sulfate (SDS) and 0.1 mg/ml protei-
nase K for 1 h at 60°C. After digestion, the viral DNA was
extracted twice with an equal volume of phenol:chloro-
form:isoamyl alcohol (25:24:1) and precipitated with
2 volumes of cold ethanol and 0.3 M NaCl. The pellet
obtained was rinsed with 600 μl of 70% ethanol, dried and
re suspended in 50 μl of nuclease free water and stored at
-20°C until use. DNA concentration and purity was mea-
sured by BioPhotometer (Eppendorf Scientific, Westbury,
NY) at 260 and 280 nm.
Differential PCR assay
The PCR designed by Claus and collaborators [39] was
carried out with some modifications. The primers were
B1 specific for BoHV-1 (5-CAA CCG AGA CGG AAA
GCT CC-3_nt 185-204); B5 specific for BoHV-5 (5-
CGG ACG AGA CGC CCT TGG-3_nt 322-339) and
consensus primer designated Bcon (5-AGT GCA CGT
ACA GCG GCT CG-3_nt 519-538). The amplification
product was 159 bp from BoHV-5 and 354 bp from
BoHV-1 (glycoprotein C gene). The multiplex-PCR was
Figure 4 PCRs amplicons before and after digestion with BstEII of all isolates andreference strains. Markers used: lane 19) 100 bp DNA
Ladder (Promega); lane 20) 1 Kb plus marker (Invitrogen). In gel we added e bar that includes the lines with the undigested PCR product and
digested PCR product for each virus. The left line of each virus: the amplicon was digested with the enzyme BstEII.
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prepared in a reaction containing 50 ng of extracted
DNA and 12.5 μl of mix-PCR consisting of 0.4 pmol of
each primer (B1, B5, and Bcon); 1.5 mMol dNTPs (Invi-
trogen TM Life Technologies, USA); 2.5 units of Taq
DNA Polymerase (Invitrogen TM Life Technologies,
USA); 1X PCR buffer (20 mM Tris-HCl pH 8.4, 50 mM
KCl); 1.5 mM MgCl2 and ultrapure sterile water to a final
volume of 12.5 μl. Amplification reactions were per-
formed in a thermocycler (Biometra TRIO - Thermo-
block) under the following conditions: one step of 10 min
at 96°C followed by 25 cycles of 1 min at 96°C; 1 min at
58°C; 1 min at 72°C and one last extension step of 10
min at 72°C. The products were analyzed on 1% agarose
gel electrophoresis, stained with ethidium bromide (0.5
μg/ml) in TBE buffer pH 8.4 (89 mM Tris, 89 mM boric
acid, 2 mM EDTA) and visualized under UV light.
Restriction endonuclease analysis (REA)
Four μg of viral DNA from each strain were cleaved
with the restriction enzyme BstEII under the conditions
recommended by the manufacturer (Promega). The
digestion products were separated by electrophoresis on
a 0.7% agarose gel at 50 V O.N. using TBE buffer pH
8.4 (89 mM Tris, 89 mM boric acid, 2 mM EDTA). The
gels were stained with ethidium bromide (1 μg/μl) and
photographed under UV light.
UL27 PCR assay
Primers were designed based on the published sequence
of BoHV-5 (Genbank accession number: AY261359) [1]
(UL27F: 5-CTG-GCA-CGA-TCG-AAC-GGC-A-3 nt
58116 and UL27R: 5-AGC-AGC-TCG-TTG-TCC-TCG-
C-3 nt 58651). A study conducted in silico with bioin-
formatic tools showed that the site that determines a
type “b” pattern is included in the open reading frame
of the glycoprotein B (UL27). DNA sequence analysis to
locate the discriminative mutant region between BoHV-
5a and BoHV-5b within the UL27 target gen was per-
formed using Vector NTI Suite version 8.0 (InforMax
Inc-Invitrogen, Merelbeke, Belgium). The assay was per-
formed with purified DNA from strains of different sub-
types. Amplification was carried out in a 50 μl reaction
mix containing 5 ng of template DNA, Taq DNA poly-
merase buffer (New England Biolabs, NEB, Ipswich,
MA, USA), 2 mM MgCl2, 6% DMSO, 200 μM dNTPs,
0.3 μM of both forward and reverse primers and 1U
TaqDNA polymerase (NEB). Annealing temperatures
were optimized for each primer pairs. PCR products
were confirmed by electrophoresis on a 2% agarose gel.
Digestion of amplified product with BstEII (PCR-REA
assay)
The purified PCR products were digested with the restric-
tion enzyme BstEII under the conditions recommended by
the manufacturer (Promega). The resulting products
were separated by electrophoresis in 1% agarose gels and
were visualized by ethidium bromide staining under UV
light.
Sequences analysis
Amplified products were purified using Illustra GFX™
PCR, DNA and gel band purification kit (GE Healthcare,
Diegem, Belgium). The quality of all DNA preparations
was evaluated by agarose gel electrophoresis. Sequencing
reactions were performed with BigDye Terminator v3.0
kit (Applied Biosystems, Lennik, Belgium) and analyzed
with ABI Prism 3730 DNA Analyzer (Applied Biosys-
tems). Each product was sequenced twice in both direc-
tions using forward and reverse primers. The deduced
nucleotide and amino-acid sequences were edited;
aligned and analyzed with BioEdit version 7.0.5.3 [52].
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